Clinical Trials Logo

Reduction of Psoriasis Following Liraglutide Therapy in Terms of PASI and DLQI clinical trials

View clinical trials related to Reduction of Psoriasis Following Liraglutide Therapy in Terms of PASI and DLQI.

Filter by:
  • None
  • Page 1

NCT ID: NCT01451905 Recruiting - Clinical trials for Reduction of Psoriasis Following Liraglutide Therapy in Terms of PASI and DLQI

GLP-1 Receptors in Normal Skin and Skin From Patients With Psoriasis

Start date: August 2011
Phase: N/A
Study type: Interventional

To examine GLP-1 receptors in skin of psoriasis patients compared with the skin of humans with no skin disease